Equity (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Summary of the Warrants

	Number of shares		Exercise price		Expiration date
Dragasac Warrants (1) (4)		652,981	$	2.4898	March 16, 2025
Public Warrants (2)		1,437,447	$	115.00	July 16, 2026
Sponsor Warrants (2)		849,999	$	115.00	July 16, 2026
May 2022 PIPE Warrants		405,405	$	3.50	October 10, 2028
March 2023 PIPE Warrants		208,485	$	30.00	March 27, 2028
March 2023 PIPE Warrants (modified)		729,698	$	10.00	March 27, 2028
March 2023 Loan Warrants		75,000	$	5.8950	March 17, 2028
April 2023 Registered Direct Warrants		435,625	$	7.50	October 10, 2028
April 2023 Registered Direct Warrants (modified)		487,451	$	3.50	October 10, 2028
May 2023 PIPE Warrants		581,394	$	10.00	May 17, 2028
June 2023 Warrants (3)		50,000	$	5.8950	June 20, 2028
June 2023 Loan Warrants		300,000	$	8.10	June 20, 2028
July 2023 Registered Direct Warrants		857,142	$	3.50	January 31, 2029
January 2024 PIPE Warrants (4)		535,274	$	2.4898	January 16, 2029
January 2024 Bridge Loan - Tranche #1 Warrants		1,650,000	$	2.4898	January 16, 2029
January 2024 Bridge Loan - Tranche #2 Warrants		1,350,000	$	2.9880	July 15, 2029
March 2024 RWI Forbearance Warrants		300,000	$	5.8958	June 20, 2028
November 2024 Purchaser Warrants		263,156	$	2.85	November 25, 2029 - December 3, 2029
November 2024 Placement Agent Warrants		52,500	$	3.56	November 25, 2029 - December 3, 2029
		11,221,557

(1)	In connection with the execution of the January 2024 PIPE described above, the Company agreed to reprice 652,981 legacy warrants held by Dragasac with a previous exercise price of $67.70 to a new exercise price of $2.4898. The term of the warrants was unchanged.
(2)	The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.
(3)	In connection with the execution of the Starr Forbearance Agreement on March 13, 2024, described above under Warrant Modification and further in Note 10, the Company agreed to reprice 75,000 warrants with a previous exercise price of $7.10 and 50,000 warrants with a previous exercise price of $8.10 held by C.V. Starr to a new exercise price of $5.895. The term of the warrants was unchanged.
(4)	On January 24, 2025, the Company agreed to reduce the exercise price of the Dragasac warrants and the January 2024 PIPE warrants from $2.49 per share to $2.07 per share. As a result of the price reduction, the holder agreed to immediately exercise the warrants in full and to purchase an aggregate 1,188,255 shares of the Company’s Class A common stock for gross proceeds to the Company of approximately $2.5 million.